Category Archives: Nasdaq 100 Watch List

Nasdaq 100 Watch List: June 20, 2014

Below is the performance of the twelve stocks from our June 21, 2013 Nasdaq 100 watch list (found here) compared to the Nasdaq 100 Index gain of +32.13% over the last year.

Symbol Name 2013 2014 % change
FFIV F5 Networks, Inc. 70.92 108.81 53.43%
NUAN Nuance Communications 18.5 19.47 5.24%
GOLD Randgold Resources Limited 66.712 82.25 23.29%
INTU Intuit Inc. 57.86 79.5 37.40%
TEVA Teva Pharmaceutical 38.74 52.97 36.73%
CTXS Citrix Systems, Inc. 59.988 64.93 8.24%
GRMN Garmin Ltd. 34.69 60.05 73.10%
AAPL Apple Inc. 59.07 90.91 53.90%
CHRW CH Robinson Worldwide 54.79 63.92 16.66%
ALTR Altera Corp. 31.99 35.04 9.53%
ALXN Alexion Pharmaceuticals 88.492 165.46 86.98%
EXPD Expeditors Int’l of WA 37.05 44.49 20.08%
Average 35.38%

Standout performers were Alexion Pharmaceuticals, Garmin, Apple and F5 Networks.  The stocks that underperformed were Nuance Communications, Citrix Systems and Altera Corp.  The top 5 stocks on the list gained as average of only +31.22% in the last year which is less that the benchmark Nasdaq 100 Index.

Nasdaq 100 Watch List: June 20, 2014

Below is the latest watch and estimated targets.

Continue reading

Nasdaq 100 Watch List: May 30, 2014

Performance Review

In our Nasdaq 100 Watch List from May 24, 2013 (found here), we had the following performance of the top five stocks (May 24, 2013 to May 23, 2014):

Symbol Name 2013 2014 % change
TEVA Teva Pharmaceutical 39.34 51.77 31.60%
INTU Intuit Inc. 57.9 79.59 37.46%
NUAN Nuance Communications, Inc. 19.21 15.8 -17.75%
GRMN Garmin Ltd. 35.12 57.39 63.41%
ISRG Intuitive Surgical, Inc. 501.53 363.86 -27.45%
Average 17.45%
^NDX Nasdaq 100 Index 22.95%

The top five stocks underperformed the Nasdaq 100 by -5.50%.  However, the stock that we had a strong interest in, Teva Pharmaceutical (TEVA), garnered the following commentary:

“…Teva appears to have all of the attributes that we’re looking for in both the short and long-term.  Teva has earnings that can support a reasonable dividend with a margin for error if annual earnings were to decline -40%.  According to Value Line Investment Survey, Teva is selling 70% below fair value based on 2012 cash flow of $7.44 per share.  For all intents and purposes, we believe that Teva has long term viability…”

“…The strategy for taking advantage of the relative low in the price is to break the purchase of Teva into 2 or 3 stages.  In either scenario, buying now would be a reasonable reaction to the current price.”

TEVA never fell as low as we had expected.  However, the recommendation of purchasing TEVA at the price indicated was appropriate and has generated reasonable gains.

We’d like to add that while our overall list from last year didn’t exceed the market, it would have done much better had we excluded Intuitive Surgical (ISRG) and Nuance Communications (NUAN).  We believe that ISRG could be excluded because on March 19, 2013 (found here), we said the following of the stock:

“The next stock of interest is Intuitive Surgical (ISRG).  The last time the stock was our watch list was in November 26, 2010 at a price of $275.08 (found here).  As with our observation on Apple’s (AAPL) contracting volume as the price rose, ISRG has experienced the same phenomenon (found here). In addition, as ISRG has declined recently, the amount of average volume has increased dramatically. This suggests that there may be support for the idea that this stock could fall much lower from the current levels.

image

“According to Dow Theory, ISRG has downside targets of $426.91, $342.92 and $258.93.  We think that $426.91 AND $342.92 are a lock for the downside risk.  A decline below $342.92 suggests that $299 and below is the next target.”

We believe that pointing out the conflicting trend of price and volume was fair warning that ISRG was at risk of continuing the declining trend.  As recently as May 9, 2014, ISRG has decline as low as $346.46 or within 2% of our Dow Theory downside target.  Nuance Communications (NUAN) was not highlighted as a stock of interest to us within the last year.

On the opposite side of our “negative” view on ISRG or absence of interest with NUAN, our commentary on Intuit (INTU) is best represented in our review of the stock from our June 7, 2013 watch list (found here):

“While Garmin (GRMN) appears to be the best value on our Watch List this week, Intuit (INTU) seems the most compelling.  Applying Dow Theory to Intuit’s price we get the following downside targets:

  • $51.98
  • $44.03
  • $38.08

image

“Based on Dow Theory, Intuit has a minimum downside target to the 1/3 level ($51.98) which seems to have provided a surprising support level at the red arrows.  However, this is price action within a confirmed bull market.  What we want to know is what could happen if we enter a bear market.

“In the decline from the October 2006 peak to the December 2009 trough, Intuit fell as much as –43.54%.  If Intuit were to decline by a similar amount from peak to trough, the stock would fall as low as $38.62.  Our bear market calculation almost matches our lowest Dow Theory downside target of $38.08. Finally, if we assume a –43.54% decline from the current price of $59.46 we arrive at a price of $33.47, this is only 12.10% below the Dow Theory low.  The bottom line on Intuit is that the downside risk is fairly limited.”

Excluding the performance of NUAN and ISRG, our watch list would have gained +44.16%.  While we can’t take credit for all the coincidental postings and the subsequent performance, we hope that our measured approach to analyzing these stocks has broadened your perspective as an investor.

Nasdaq 100 Watch List: May 30, 2014

Below are the 14 stocks that we’re currently tracking from the Nasdaq 100:

Nasdaq 100 Watch List: May 9, 2014

Below is the watch list of stocks that we are following from the Nasdaq 100 Index.

Nasdaq 100 Watch List: April 25, 2014

Watch List Performance Review

Below is the performance of the stocks from our April 26, 2013 watch list (found here):

Symbol Name % change
BIDU Baidu, Inc. 91.61%
EXPD Expeditors International. 13.07%
FFIV F5 Networks, Inc. 39.51%
TEVA Teva Pharmaceutical 26.30%
ALTR Altera Corp. 6.06%
GRMN Garmin Ltd. 56.22%
ISRG Intuitive Surgical, Inc. -24.73%
AVGO Avago Technologies Limited 94.15%
AAPL Apple Inc. 37.09%
WFM Whole Foods Market, Inc. -42.84%
CTXS Citrix Systems, Inc. -3.85%
  Average 26.60%

The performance of the entire watch list exceeded the Nasdaq 100 Index gain of +24.38% over the last year.  However, the top five stocks from the above list had an average gain of +35.31% and is charted below:

image

The ability of the top five stocks to exceed the Nasdaq 100 Index can be solely attributed to the performance of Baidu (BIDU).  Without the performance of Baidu, the remaining four stocks would have averaged a gain of +21.24%.  However, at the time, we said:

…all indications, based on the SRL, are that Baidu is worth considering in a two stage purchase plan, once at the current level and again at $67 or lower.” 

The opportunity to purchase Baidu at $67 or lower never arrived.  Making recommendations of a stock simply because the price had declined isn’t easy.  However, all fundamental AND technical indications were suggesting that Baidu was worth considering, at the time.

Nasdaq 100 Watch List: April 25, 2014

Below are the 14 Nasdaq 100 stocks that we think are worth your consideration:

Nasdaq 100 Watch List: April 11, 2014

Below are the fifteen Nasdaq 100 companies that are on our radar with the analyst estimates of price performance for the remainder of 2014.

Nasdaq 100 Watch List: March 14, 2014

March 19, 2013 Performance Review

Below is the performance of the nine stocks from our March 19, 2013 Nasdaq 100 watch list (found here) compared to the performance of the Nasdaq 100 Index gain of +29.63% over the last year.

Symbol Name 2013 2014 % change
GRMN Garmin Ltd. 34.23 52.19 52.47%
BIDU Baidu, Inc. 84.81 160.59 89.35%
NUAN Nuance Communications, Inc. 18.51 15.95 -13.83%
ISRG Intuitive Surgical, Inc. 481.76 423.07 -12.18%
WFM Whole Foods Market, Inc. 43.07 53.93 25.21%
MSFT Microsoft Corporation 28.08 37.7 34.26%
ROST Ross Stores Inc. 55.81 72.67 30.21%
AAPL Apple Inc. 458.91 524.69 14.33%
LMCA Liberty Media Corporation 111.5 135.25 21.30%
Average +26.79%

Below is the performance of the top five stocks on the watch list from last year. The average gain was +28.20%.

image

Garmin (GRMN) was a stock of interest to us last year.  While we liked GRMN, we suggested that the stock had downside risk of –22%.  In retrospect, potentially losing –25% was a decent risk/reward proposition.  Last month we recommended that the principal be sold in GRMN in order to secure investment gains.  For now, the stock has declined marginally.

We highlighted Intuitive Surgical (ISRG) with a concern that the stock had price gains without the necessary rising trading volume.  We said the following:

“As with our observation on Apple’s (AAPL) contracting volume as the price rose, ISRG has experienced the same phenomenon (found here). In addition, as ISRG has declined recently, the amount of average volume has increased dramatically. This suggests that there may be support for the idea that this stock could fall much lower from the current levels.”

Dow Theory indicated that downside risk was to $426 and $342 levels.  Although ISRG easily achieved the $426 downside target the $342 target was missed by 2.5%. As seen in the performance chart above, ISRG declined as much as –26% within the last year and currently lingers with a –12% loss.

The last stock that we mentioned was Whole Foods Market (WFM).  We said the following of WFM:

“Finally, Whole Foods (WFM) is on our watch list for the first time since the July 23, 2009 Dow Theory bull market initiation of the New Low Observer.  In the run up to the 2005 peak and December 2008 bottom, Whole Foods had had increasing volume all the way.  However, as the stock price rose from the 2008 low, Whole Foods has had a continued decline in trading volume.  More recently though, the decline from the October 5, 2012 top has resulted in higher average volume indicating that those wishing to get out are doing it in “droves.”  Dow Theory suggests that the following downside targets are $70.25, $54.44 and $38.64.  Whole Foods falling to the $70.25 level could mean that the situation is dire, from a price standpoint.”

Since our commentary on Whole Foods, the stock has only increased in value.  In fact, March 19, 2013 marked a lull in the stock price before rising nearly +52%.

image

The performance of Whole Foods Market was in stark contrast to our analysis at the time.  This reiterates the importance of considering stocks on our watch list as a decent starting point for investment opportunities.

March 14, 2014 Nasdaq 100 Watch List

Below are the eight Nasdaq 100 stocks that are of interest to us.

Nasdaq 100 Watch List: February 21, 2014

Performance Review

Below is the performance of the twelve stocks from the February 22, 2013 Nasdaq 100 watch list (found here) compared to the performance of the Nasdaq 100 Index gain of +33.80%.

symbol
Name 2013 2014 % change
GRMN Garmin Ltd. $35.00 51.97 48.49%
VOD Vodafone Group $25.01 39 55.94%
NUAN Nuance Communications $18.66 15.07 -19.24%
AAPL Apple Inc. $450.81 525.25 16.51%
BIDU Baidu, Inc. $89.18 172.66 93.61%
TEVA Teva Pharmaceutical $38.08 48.45 27.23%
MSFT Microsoft Corporation $27.76 37.98 36.82%
BBBY Bed Bath & Beyond Inc. $57.60 64.99 12.83%
LMCA Liberty Media Corporation $107.14 135.87 26.82%
INTC Intel Corporation $20.42 24.42 19.59%
WFM Whole Foods Market, Inc. $85.83 52.76 -38.53%
ALXN Alexion Pharmaceuticals, Inc. $87.44 181.52 107.59%
Average 32.30%

Below is the performance of the top five stocks on the watch list from last year.  The average gain was +39.06%.

image

Garmin (GRMN) was the stock of interest to us at the time.  We had the expectation that GRMN would decline to the $30 level, however, it never happened.  GRMN has consistently increased in value and recently achieved a new high.  Given the considerable increase in GRMN in the last year, selling the principal should be considered at this point.

The purpose of our work is to demonstrate that high quality stocks that appear down and out are worthy of consideration.

February 21, 2014 Nasdaq 100 Watch List

Below are the six Nasdaq 100 companies that are on our radar with the analyst estimates of downside risk for the coming year.

Continue reading

Nasdaq 100 Watch List: January 10, 2014

Performance Review

Below is the performance of the eight stocks from the January 11, 2013 Nasdaq 100 watch list (found here) compared to the performance of the Nasdaq 100 Index.

Symbol
Name 2013 2014 % change
MSFT Microsoft Corp 26.83 36.04 34.33%
DLTR Dollar Tree, Inc. 38.12 55.89 46.62%
BBBY Bed Bath & Beyond 56.27 69.94 24.29%
TEVA Teva Pharmaceutical 38.06 41.87 10.01%
VOD Vodafone Group  26.59 38.69 45.51%
PAYX Paychex, Inc. 31.78 44.37 39.62%
NVDA NVIDIA Corporation 12.21 15.73 28.83%
CA CA Technologies 23.34 34.02 45.76%
34.37%
^NDX NASDAQ-100 2,748.26 3565.08 29.72%

image

On average, the watch list from last year gained +34.37%.  This is contrasted with the Nasdaq 100 gaining an average of +29.37%.  Of the top five stocks on our list, only Teva Pharmaceutical (TEVA) did not exceed the performance of the Nasdaq 100 throughout the year.  Additionally, Bed Bath and Beyond (BBBY) outpaced the Nasdaq 100 until recently.  Dollar Tree (DLTR) registered the best performance for the entire list even though the stock is down –7.35% from the November peak.

January 10, 2014 Nasdaq 100 Watch List

Below are the six Nasdaq 100 companies that are on our radar with the analyst estimates of downside risk for the coming year.

Nasdaq 100 Watch List: December 6, 2013

Below are the eight Nasdaq 100 companies that are on our radar. Also, we review analyst estimates for the stocks on our list, the altimeter of an individual stock and the exceptional performance of our top five stocks from one year ago.

Nasdaq 100 Watch List: November 27, 2013

Below are the Nasdaq 100 companies that are within 10% of their respective 52-week lows. Stocks that appear on our watch lists are not recommendations to buy. Instead, they are the starting point for doing your research and determining the best company to buy. Ideally, a stock that is purchased from this list is done after a considerable decline in the price and rigorous due diligence.

Continue reading

Nasdaq 100 Watch List: November 1, 2013

Below are the Nasdaq 100 companies that are within 10% of their respective 52-week lows. Stocks that appear on our watch lists are not recommendations to buy. Instead, they are the starting point for doing your research and determining the best company to buy. Ideally, a stock that is purchased from this list is done after a considerable decline in the price and rigorous due diligence.

Continue reading

Nasdaq 100 Watch List: October 11, 2013

Below are the Nasdaq 100 companies that are within 10% of their respective 52-week lows. Stocks that appear on our watch lists are not recommendations to buy. Instead, they are the starting point for doing your research and determining the best company to buy. Ideally, a stock that is purchased from this list is done after a considerable decline in the price and rigorous due diligence.

Continue reading

Nasdaq 100 Watch List: August 30, 2013

Below are the top Nasdaq 100 companies that are within 10% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models. These companies are deemed highly speculative unless otherwise noted. Continue reading

Nasdaq 100 Watch List: August 23, 2013

Below are the Nasdaq 100 companies that are within 10% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models.

Continue reading

Nasdaq 100 Watch List: July 26, 2013

Below are the Nasdaq 100 companies that are within 10% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models. Continue reading